Evidence map›Paper›PMID 34050204›Full record

ArticleScientific reports2021

Ultraviolet radiation protection potentials of Methylene Blue for human skin and coral reef health.

Zheng-Mei Xiong, Xiaojing Mao, Mason Trappio, Chanda Arya, Jasmin El Kordi, Kan Cao

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Zheng-Mei Xiong *Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, MD, USA.
Xiaojing MaoDepartment of Cell Biology and Molecular Genetics, University of Maryland, College Park, MD, USA.
Mason TrappioDepartment of Cell Biology and Molecular Genetics, University of Maryland, College Park, MD, USA.
Chanda AryaDepartment of Cell Biology and Molecular Genetics, University of Maryland, College Park, MD, USA.
Jasmin El KordiMblue Labs, Bethesda, MD, USA.
Kan CaoDepartment of Cell Biology and Molecular Genetics, University of Maryland, College Park, MD, USA. kcao@umd.edu.
University of Maryland, College Park · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Methylene blue (MB) is a century-old medicine, a laboratory dye, and recently shown as a premier antioxidant that combats ROS-induced cellular aging in human skins. Given MB's molecular structure and light absorption properties, we hypothesize that MB has the potential to be considered as a sunscreen active for UV radiation protection. In this study, we tested the effects of MB on UVB ray-induced DNA double-strand breaks in primary human keratinocytes. We found that MB treatment reduced DNA damages caused by UVB irradiation and subsequent cell death. Next, we compared MB with Oxybenzone, which is the most commonly used chemical active ingredient in sunscreens but recently proven to be hazardous to aquatic ecosystems, in particular to coral reefs. At the same concentrations, MB showed more effective UVB absorption ability than Oxybenzone and significantly outperformed Oxybenzone in the prevention of UVB-induced DNA damage and the clearance of UVA-induced cellular ROS. Furthermore, unlike Oxybenzone, MB-containing seawater did not affect the growth of the coral species Xenia umbellata. Altogether, our study suggests that MB has the potential to be a coral reef-friendly sunscreen active ingredient that can provide broad-spectrum protection against UVA and UVB.

Indexed as

AgingAnimalsAnthozoaAntioxidantsBenzophenonesCoral ReefsDNA Breaks, Double-StrandedDNA DamageEcosystemHumansKeratinocytesLightMethylene BlueRadiation ProtectionSkinSunscreening AgentsAntioxidantsBenzophenonesMethylene BlueoxybenzoneSunscreening Agents

Identifiers

PMID34050204
PMCPMC8163870
OpenAlexW3135620730

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.